Zynx Health Updates and Expands Its Free-of-Charge COVID-19 Clinical Decision Support

LOS ANGELES--(BUSINESS WIRE)-- Zynx Health® today announced that it has significantly expanded and updated the publicly accessible COVID-19 clinical decision support available on its website, zynxhealth.com. The latest updates that have been incorporated into the Zynx Health content include recommendations from organizations such as the Infectious Diseases Society of America, Centers for Disease Control and Prevention, and World Health Organization. Zynx Health’s COVID-19 content, in addition to order sets and care plans, includes guidance on diagnostic testing, admission/discharge criteria, transmission-based precautions, therapy, supportive care, and treatment of special populations including pregnant patients.

A pioneer in electronic clinical decision support, Zynx Health began publishing COVID-19 guidance free of charge on March 18, 2020. The content has since been expanded and refined more than 30 times since as new information on diagnosing, treating, and managing the virus – across the entire continuum of care – has been reviewed and published. The Zynx content has been accessed more than 20,000 times to date.

“Since its inception in 1996, the mission of Zynx Health has been to provide healthcare professionals with vital and necessary information to drive better patient outcomes,” said John Chang, MD, PhD, MPH, FAC, senior vice president and head of the Zynx clinical team. “We recognized in early March 2020 the importance of making our COVID-19 guidance freely available. Since then, the entire Zynx Health clinical team – our physicians, nurses, and pharmacists – has continued to update the content as soon as information from trusted resources becomes available. This model fully aligns with Zynx Health’s mission of helping to ensure that healthcare professionals have access to the most recent and best available information for hundreds of conditions ranging from abdominal aortic aneurysm to wound care.”

For more information and to view Zynx Health’s complimentary COVID-19 content, visit zynxhealth.com or zynxhealth.com/covid-19.

About Zynx Health

Zynx Health, a market leader in providing evidence- and experience-based clinical improvement solutions since 1996 and part of the Hearst Health network, provides healthcare professionals with vital information and processes that guide care decisions and reduce complexity across the entire patient journey in a way that leads to healthier lives for all. Zynx is a pioneer and market leader in evidence- and experience-based clinical solutions that help health systems improve patient outcomes, financial outcomes, clinical engagement, and technology performance. With Zynx Health, healthcare organizations exceed industry demands for delivering high-quality care at lower costs under value-based reimbursement models. To learn more, visit zynxhealth.com or call 888.996.9435. Follow Zynx Health on Twitter @ZynxHealth and LinkedIn @Zynx-Health.

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201204005474/en/